Literature DB >> 21126707

Treatment of GERD complications (Barrett's, peptic stricture) and extra-oesophageal syndromes.

Ajay Bansal1, Peter J Kahrilas.   

Abstract

Apart from typical reflux symptoms and oesophagitis, the clinical presentation of GERD can be dominated by mucosal complications of reflux (Barrett's oesophagus, oesophageal adenocarcinoma, Peptic structure) or by extra-oesophageal syndromes, most notably asthma, laryngitis, or chronic cough. Managing these entities is much less straightforward than with oesophagitis. With respect to adenocarcinoma, metaplasia and dysplasia are recognised precursors, but the potential of these lesions to evolve to cancer has not been shown to lessen as a result of treatment, medical or surgical. Consequently, management focuses on strategies to identify and eliminate high-grade dysplasia and intramucosal cancer, lesions that are potentially curable by endoscopic ablation or surgical resection. With respect to the extra-oesophageal GERD syndromes, these are increasingly recognised as multifactorial conditions with reflux as an exacerbating factor. Treatment trials have been generally disappointing and the clinical challenge remains in accurately identifying afflicted patients who might benefit from more intensive medical or surgical reflux treatment. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21126707      PMCID: PMC3006235          DOI: 10.1016/j.bpg.2010.09.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  46 in total

Review 1.  Review article: approaches to Barrett's oesophagus treatment-the role of proton pump inhibitors and other interventions.

Authors:  J Jankowski; P Sharma
Journal:  Aliment Pharmacol Ther       Date:  2004-02       Impact factor: 8.171

2.  Does laparoscopic fundoplication provide long-term control of gastroesophageal reflux related cough?

Authors:  C J Allen; M Anvari
Journal:  Surg Endosc       Date:  2004-03-19       Impact factor: 4.584

3.  Low-grade dysplasia in Barrett's esophagus.

Authors:  Prateek Sharma
Journal:  Gastroenterology       Date:  2004-10       Impact factor: 22.682

4.  Pneumomediastinum after self-dilation of the esophagus.

Authors:  M M Noppen; L Corne; O Peters; L Smekens; W Musch; W Vincken
Journal:  Chest       Date:  1987-10       Impact factor: 9.410

5.  Prospective randomized comparison of polyvinyl bougies and through-the-scope balloons for dilation of peptic strictures of the esophagus.

Authors:  Z A Saeed; C B Winchester; P S Ferro; P A Michaletz; J T Schwartz; D Y Graham
Journal:  Gastrointest Endosc       Date:  1995-03       Impact factor: 9.427

6.  Self-bougienage in the treatment of benign esophageal stricture.

Authors:  J L Grobe; R A Kozarek; R A Sanowski
Journal:  J Clin Gastroenterol       Date:  1984-04       Impact factor: 3.062

7.  A randomized prospective study comparing rigid to balloon dilators for benign esophageal strictures and rings.

Authors:  J S Scolapio; T M Pasha; C J Gostout; D W Mahoney; A R Zinsmeister; B J Ott; K D Lindor
Journal:  Gastrointest Endosc       Date:  1999-07       Impact factor: 9.427

8.  Laparoscopic antireflux surgery for the treatment of esophageal strictures refractory to medical therapy.

Authors:  P J Klingler; R A Hinder; R A Cina; K R DeVault; N R Floch; S A Branton; M H Seelig
Journal:  Am J Gastroenterol       Date:  1999-03       Impact factor: 10.864

9.  Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus.

Authors:  Hashem B El-Serag; Thomas V Aguirre; Stephanie Davis; Mark Kuebeler; Achyut Bhattacharyya; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2004-10       Impact factor: 10.864

10.  Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.

Authors:  Kathleen E Corey; Sarah M Schmitz; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2003-11       Impact factor: 10.864

View more
  2 in total

1.  Effectiveness of salivary stimulation using xylitol-malic acid tablets as coadjuvant treatment in patients with gastro-oesophageal reflux disease: early findings.

Authors:  I Sánchez-Blanco; M Rodríguez-Téllez; J-R Corcuera-Flores; C González-Blanco; D Torres-Lagares; M-Á Serrera-Figallo; G Machuca-Portillo
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-11-01

2.  Oral pH in gastroesophageal reflux disease.

Authors:  S Sujatha; Umesh Jalihal; Yashoda Devi; N Rakesh; Pallavi Chauhan; Shivani Sharma
Journal:  Indian J Gastroenterol       Date:  2016-05-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.